A detailed history of Texas Yale Capital Corp. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Texas Yale Capital Corp. holds 4,208 shares of VRTX stock, worth $2.11 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,208
Previous 4,218 0.24%
Holding current value
$2.11 Million
Previous $1.76 Million 11.85%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $3,928 - $4,855
-10 Reduced 0.24%
4,208 $1.97 Million
Q1 2024

May 08, 2024

BUY
$407.69 - $446.08 $178,975 - $195,829
439 Added 11.62%
4,218 $1.76 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $1.3 Million - $1.55 Million
3,779 New
3,779 $1.54 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Texas Yale Capital Corp. Portfolio

Follow Texas Yale Capital Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.